Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals

TRAXVery BullishAnalyst Target Updateanalyst

High materiality8/10

First Tracks Biotherapeutics initiated with a Buy at Canaccord

Sep 30, 2026, 8:02 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Canaccord Genuity initiates TRAX with a Buy rating; target $50; last price $35.98.

Canaccord initiates BUY on TRAX
Target $50
Posted price $35.98

Key facts

01
Target: $50
02
Posted price: $35.98
03
Analyst firm: Canaccord Genuity

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.